Vaughan David Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $340K | Sell |
14,110
-198
| -1% | -$5.18K | 0.01% | 202 |
|
|
2026
Q1 | $402K | Buy |
14,308
+1,866
| +15% | +$49.7K | 0.01% | 183 |
|
|
2025
Q4 | $310K | Buy |
12,442
+25
| +0.2% | +$630 | 0.01% | 197 |
|
|
2025
Q3 | $316K | Sell |
12,417
-1,846
| -13% | -$45.6K | 0.01% | 192 |
|
|
2025
Q2 | $346K | Buy |
14,263
+1,446
| +11% | +$33.7K | 0.01% | 182 |
|
|
2025
Q1 | $325K | Buy |
12,817
+103
| +0.8% | +$2.69K | 0.01% | 176 |
|
|
2024
Q4 | $337K | Buy |
12,714
+221
| +2% | +$6K | 0.01% | 177 |
|
|
2024
Q3 | $362K | Sell |
12,493
-888
| -7% | -$25.9K | 0.01% | 171 |
|
|
2024
Q2 | $374K | Sell |
13,381
-699
| -5% | -$19.2K | 0.01% | 165 |
|
|
2024
Q1 | $391K | Sell |
14,080
-475
| -3% | -$13.2K | 0.01% | 172 |
|
|
2023
Q4 | $419K | Sell |
14,555
-7,127
| -33% | -$215K | 0.01% | 157 |
|
|
2023
Q3 | $719K | Sell |
21,682
-1,091
| -5% | -$38.6K | 0.02% | 130 |
|
|
2023
Q2 | $835K | Sell |
22,773
-815
| -3% | -$31.7K | 0.02% | 131 |
|
|
2023
Q1 | $962K | Sell |
23,588
-1,759
| -7% | -$76K | 0.03% | 126 |
|
|
2022
Q4 | $1.3M | Buy |
25,347
+299
| +1% | +$14.3K | 0.04% | 118 |
|
|
2022
Q3 | $1.1M | Sell |
25,048
-213
| -0.8% | -$10.3K | 0.04% | 120 |
|
|
2022
Q2 | $1.32M | Sell |
25,261
-301
| -1% | -$15.3K | 0.04% | 117 |
|
|
2022
Q1 | $1.32M | Sell |
25,562
-5,067
| -17% | -$263K | 0.04% | 118 |
|
|
2021
Q4 | $1.81M | Buy |
30,629
+4,596
| +18% | +$228K | 0.05% | 112 |
|
|
2021
Q3 | $1.12M | Sell |
26,033
-3,295
| -11% | -$146K | 0.04% | 117 |
|
|
2021
Q2 | $1.15M | Sell |
29,328
-7,158
| -20% | -$278K | 0.04% | 121 |
|
|
2021
Q1 | $1.32M | Sell |
36,486
-32,030
| -47% | -$1.14M | 0.04% | 112 |
|
|
2020
Q4 | $2.52M | Sell |
68,516
-16,197
| -19% | -$594K | 0.09% | 96 |
|
|
2020
Q3 | $2.95M | Sell |
84,713
-9,477
| -10% | -$332K | 0.11% | 92 |
|
|
2020
Q2 | $2.92M | Sell |
94,190
-16,175
| -15% | -$550K | 0.12% | 88 |
|
|
2020
Q1 | $3.42M | Sell |
110,365
-644,884
| -85% | -$22M | 0.16% | 89 |
|
|
2019
Q4 | $28.1M | Sell |
755,249
-8,356
| -1% | -$298K | 1.03% | 38 |
|
|
2019
Q3 | $26M | Buy |
763,605
+1,899
| +0.2% | +$69.1K | 1% | 46 |
|
|
2019
Q2 | $31.3M | Sell |
761,706
-3,540
| -0.5% | -$141K | 1.24% | 20 |
|
|
2019
Q1 | $30.8M | Buy |
765,246
+849
| +0.1% | +$34K | 1.3% | 20 |
|
|
2018
Q4 | $31.7M | Sell |
764,397
-49,969
| -6% | -$2.07M | 1.48% | 15 |
|
|
2018
Q3 | $34M | Sell |
814,366
-19,265
| -2% | -$742K | 1.44% | 15 |
|
|
2018
Q2 | $28.7M | Buy |
833,631
+6,920
| +0.8% | +$236K | 1.33% | 18 |
|
|
2018
Q1 | $27.8M | Buy |
826,711
+10,152
| +1% | +$349K | 1.32% | 22 |
|
|
2017
Q4 | $28.1M | Buy |
816,559
+19,867
| +2% | +$677K | 1.3% | 22 |
|
|
2017
Q3 | $27M | Sell |
796,692
-5,318
| -0.7% | -$171K | 1.33% | 19 |
|
|
2017
Q2 | $25.6M | Buy |
802,010
+15,240
| +2% | +$481K | 1.29% | 22 |
|
|
2017
Q1 | $25.5M | Buy |
786,770
+14,437
| +2% | +$455K | 1.32% | 20 |
|
|
2016
Q4 | $23.8M | Buy |
772,333
+5,897
| +0.8% | +$180K | 1.27% | 26 |
|
|
2016
Q3 | $24.6M | Sell |
766,436
-25,051
| -3% | -$838K | 1.34% | 20 |
|
|
2016
Q2 | $26.4M | Buy |
791,487
+3,276
| +0.4% | +$105K | 1.46% | 12 |
|
|
2016
Q1 | $22.2M | Buy |
788,211
+7,964
| +1% | +$227K | 1.26% | 31 |
|
|
2015
Q4 | $23.9M | Sell |
780,247
-1,256
| -0.2% | -$39.5K | 1.44% | 15 |
|
|
2015
Q3 | $23.3M | Sell |
781,503
-25,586
| -3% | -$820K | 1.47% | 12 |
|
|
2015
Q2 | $25.7M | Buy |
807,089
+639
| +0.1% | +$20.8K | 1.52% | 13 |
|
|
2015
Q1 | $26.6M | Sell |
806,450
-24,585
| -3% | -$782K | 1.58% | 10 |
|
|
2014
Q4 | $24.6M | Sell |
831,035
-17,900
| -2% | -$513K | 1.42% | 15 |
|
|
2014
Q3 | $23.8M | Buy |
848,935
+7,442
| +0.9% | +$209K | 1.45% | 14 |
|
|
2014
Q2 | $23.7M | Sell |
841,493
-454
| -0.1% | -$12.9K | 1.42% | 18 |
|
|
2014
Q1 | $25.7M | Buy |
841,947
+2,725
| +0.3% | +$81.2K | 1.6% | 9 |
|
|
2013
Q4 | $24.4M | Sell |
839,222
-1,078
| -0.1% | -$31.4K | 1.57% | 14 |
|
|
2013
Q3 | $22.9M | Sell |
840,300
-34,748
| -4% | -$945K | 1.59% | 10 |
|
|
2013
Q2 | $23.3M | Buy |
+875,048
| New | +$24.2M | 1.64% | 10 |
|
Other funds holding PFE
Vaughan David Investments's PFE Position: Q2 2026 in Review
Vaughan David Investments reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $5.18K and leaving 14,110 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #202.
Vaughan David Investments first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $34M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Vaughan David Investments held 14,110 shares of Pfizer worth $340K as of Q2 2026.
- Vaughan David Investments sold 198 Pfizer shares in Q2 2026, an estimated $5.18K.
- Pfizer made up 0.01% of Vaughan David Investments's portfolio in Q2 2026, its #202 holding.
- Vaughan David Investments first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Vaughan David Investments's Pfizer position peaked at $34M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Vaughan David Investments's 13F filing for Q2 2026, filed 11 Aug 2026.